Transforming growth factor-β and nitrates in epithelial ovarian cancer

Disease Markers

Volumn 15, Issue 4, 1999, Pages 249-258

  Khalifa, Ali ^a   Kassim, Samar K ^a,b   Ahmed, Maha I ^a   Fayed, Salah T ^b  

^a Faculty of Veterinary Medicine   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Nitrates; NO; Ovarian cancer; Synthetic phase fraction; TGF

Indexed keywords

NITRATE; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

FALLOPIA;

EID: 0033383438     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/956707     Document Type: Article

References (40)

1. [1] Bartlett, J.M., Langdon, S.P., Scott, W.N., Love, S.B., Miller, E.P., Katsaros, D., Smyth, J.F. and Miller, W.R. Transforming growth factor-beta isoform expression in human ovarian tumours. Eur. J. Cancer 33, (1997) 2397-2403.
2. [2] Berchuck, A., Kohler, M.F., Boente, M.P., Rodrigues, G.C. and Whitaker, R.S. Growth regulation and tranformation of ovarian epithelium. Cancer 71, (1993) 545-551.
3. [3] Berchuck, A., Rodrigues, G.C., Olt, G.J., Boente, M.P., Whitaker, R.S., Arrick, B., Clarke-Pearson, D.L. and Bast, R.C. Jr. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am. J. Obstet. Gynecol. 166, (1992) 676-684.
4. [4] Bories, P.N. and Bories, C. Nitrate determination in biological fluids by an enzymatic one step assay with nitrate reductase. Clin. Chem. 41, (1995) 904-907.
5. [5] Bradford, M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 62, (1976) 248-251.
6. [6] Calmels, S., Hainaut, P. and Ohshima, H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res. 57, (1997) 3365-3369.
7. [7] Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.) 362, (1993) 849-852.
8. [8] Cox, D.R. and Oakes, D. Analysis of survival data. Chapmann Hall, New York, (1984).
9. [9] Eissa, S. and El-Sharkawy, T. Correlation of c-erbB-2 oncogene expression: DNA cell cycle kinetics in colorectal carcinoma. Egypt J. Biochem. 11, (1993) 273-276.
10. [10] Eissa, S., Khalifa, A., Laban, M., Elian, A. and Bolton, W.E. Comparison of flow cytometric DNA content analysis in fresh and paraffin-embedded ovarian neoplasms: a prospective study. Br. J. Cancer 77, (1998) 421-425.
11. [11] FIGO staging as published in Am. J. Obstet. Gynecol. 156, (1987) 263.
12. [12] Fynan, T.M. and Reiss, M, Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit. Rev. Oncog. 4, (1993) 493-540.
13. [13] Grady, W.M., Rajput, A., Myeroff, L., Liu, D.F., Kwon, K., Willis, J. and Markowitz, S. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res. 58, (1998) 3101-3104.
14. [14] Guo, Y. and Kyprianou, N. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ. 9, (1998) 185-193.
15. [15] Hamilthon, T.C. Ovarian cancer; part I: biology. Curr. Probl. Cancer 16, (1992) 1-57.
16. [16] Henderson, R. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann. Clin. Biochem. 30, (1993) 521-539.
17. [17] Henry, Y., Lepoivre, M., Drapier, J.C., Ducrocq, C., Boucher, J.L. and Guissani, A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7, (1993) 1124-1134.
18. [18] Hurteau, J.A., Rodriguez, G.C., Whitacker, R.S., Shah, S., Mills, G., Bast, R.C. Jr. and Berchuck, A. Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascitis. Cancer (Phila.) 74, (1994) 93-99.
19. [19] Ignotz, R.A. and Massague, J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, (1987) 4337-4345.
20. [20] Kang, S.H., Won, K., Chung, H.W., Jong, H.S., Song, Y.S., Kim, S.J., Bang, Y.J. and Kim, N.K. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta. Int. J. Cancer 22, (1998) 620-625.
21. [21] Kaplan, E.L. and Meier, P. Non-parametric estimation from incomplete observations. Am. Stat. Assoc. 53, (1958) 457.
22. [22] Kassim, S.K. Determination of cytosolic nitrite and nitrate as indicators of nitric oxide level in ovarian cancer cells. CMB 4(3), (1997) 1051-1059.
23. [23] Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B. and Fornace, A.J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telengiectasia. Cell 71, (1992) 587-597.
24. [24] Kohler, M.F., Kerns, B.J., Humphrey, P.A., Marks, J.R., Bast, R.C. and Berchuck, A. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet. Gynecol. 81, (1993) 643-650.
25. [25] Koichi, D., Akaika, H., Horie, H. and Maeda, H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77, (1996) 1598-1604.
26. [26] Loo, S.A., Lesoon-Wood, L.A. and Cooney, R.V. Effects of tamoxifen on nitric oxide synthesis and neoplastic transformation in C3H 10t1/2 fibroblasts. Cancer Lett. 122, (1998) 67-75.
27. [27] Mabrouk, G.M., Helal, S.A., El-Lamie, K.I. and Khalifa, A. Quantitative measurement of c-erb B-2 p185 and mutant p53 expression in ovarian neoplasms by EIA. Clin. Chem. 42, (1996) 981-985.
28. [28] Maeda, H., Akaike, T., Yoshida, N.M., Stato, K., and Kuchi, Y. A new nitric oxide scavenger, imidazolineoxyl N-oxide derevative, and its effect in pathophysiology and microbiology. In: Koprowski, H. and Maeda, H. (Eds.) The role of nitric oxide in physiology and pathophysiology. Springer-Verlag, Berlin, (1995) 37-50.
29. [29] Massague, J. Receptors for the TGF-β family. Cell 69, (1992) 1067-1070.
30. [30] Massague, J. TGF-beta signal transduction. Annu. Rev. Biochem. 67, (1998) 753-791.
31. [31] Nakanishi, Y., Kodama, J., Yoshinouchi, M., Tokumo, K., Kamimura, S., Okuda, H. and Kudo, T. The expression of vascular endothelial growth factor and transforming growth factor-β associates with angiogenesis in epithelial ovarian cancer. Int. J. Gynecol. Pathol. 16, (1997) 256-262.
32. [32] Nathan, C. and Xie, Q.W. Nitric oxide synthase: roles, tolls, and controls. Cell 78, (1994) 915-918.
33. [33] Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnok, J.S. and Tannenbaum, S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Nau. Acad. Sci. USA 89, (1992) 3030-3034.
34. [34] Oft, M., Heider, K.H. and Beug, H. TGF-beta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8, (1998) 1243-1252.
35. [35] Pepper, M.S., Vassalli, J.D., Prci, L. and Montesano, R. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp. Cell Res. 204, (1993) 356-363.
36. [36] Piver, M.S., Baker, T.R., Piedmonte, M. and Sandecki, A.M. Epidemiology and etiology of ovarian cancer. Sem. Oncol. 18, (1991) 177-185.
37. 1 in murine keratinocytes. Cancer Res. 53, (1993) 899-904.
38. [38] Rideout, W.M., Coetzer, G.A., Olumi, A.F. and Jones, P.A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249, (1990) 1288-1290.
39. [39] Thomson, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros Moreno, V. and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54, (1994) 1352-1354.
40. [40] Wrana, J.L., Attisano, L., Wieser, R., Ventura, F. and Massague, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.) 370, (1994) 341-347.